Statement of Changes in Beneficial Ownership (4)
September 14 2017 - 7:27PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
GOETZ JOHN
|
2. Issuer Name
and
Ticker or Trading Symbol
BIO RAD LABORATORIES INC
[
BIO, BIOB
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
EVP, Chief Operating Officer
|
(Last)
(First)
(Middle)
C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/13/2017
|
(Street)
HERCULES, CA 94547
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
M
|
|
650
|
A
|
$107.32
|
66067.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
F
|
|
491
|
D
|
$220.47
|
65576.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
M
|
|
640
|
A
|
$117.00
|
66216.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
F
|
|
497
|
D
|
$220.47
|
65719.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
M
|
|
1200
|
A
|
$119.54
|
66919.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
F
|
|
938
|
D
|
$220.47
|
65981.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
M
|
|
1600
|
A
|
$139.56
|
67581.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
F
|
|
1320
|
D
|
$220.47
|
66261.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
M
|
|
1600
|
A
|
$159.32
|
67861.3235
|
D
|
|
Bio-Rad A Common Stock
|
9/13/2017
|
|
F
|
|
1388
|
D
|
$220.47
|
66473.3235
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Non-Qualified Stock Option (right to buy)
|
$107.32
|
9/13/2017
|
|
M
|
|
|
650
|
(1)
|
9/12/2022
|
Bio-Rad A Common Stock
|
650
|
$0
|
0
|
D
|
|
Non-Qualified Stock Option (right to buy)
|
$117.00
|
9/13/2017
|
|
M
|
|
|
640
|
(2)
|
9/11/2023
|
Bio-Rad A Common Stock
|
640
|
$0
|
640
|
D
|
|
Non-Qualified Stock Option (right to buy)
|
$119.54
|
9/13/2017
|
|
M
|
|
|
1200
|
(3)
|
9/10/2024
|
Bio-Rad A Common Stock
|
1200
|
$0
|
2400
|
D
|
|
Non-Qualified Stock Option (right to buy)
|
$139.56
|
9/13/2017
|
|
M
|
|
|
1600
|
(4)
|
9/11/2025
|
Bio-Rad A Common Stock
|
1600
|
$0
|
4800
|
D
|
|
Non-Qualified Stock Option (right to buy)
|
$159.32
|
9/13/2017
|
|
M
|
|
|
1600
|
(5)
|
9/7/2026
|
Bio-Rad A Common Stock
|
1600
|
$0
|
6400
|
D
|
|
Explanation of Responses:
|
(1)
|
The option vests in five equal annual installments beginning September 12, 2013.
|
(2)
|
The option vests in five equal annual installments beginning September 11, 2014.
|
(3)
|
The option vests in five equal annual installments beginning September 10, 2015.
|
(4)
|
The option vests in five equal annual installments beginning September 11, 2016.
|
(5)
|
The option vests in five equal annual installments beginning September 7, 2017.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
GOETZ JOHN
C/O BIO-RAD LABORATORIES, INC.
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
|
|
|
EVP, Chief Operating Officer
|
|
Signatures
|
John Goetz
|
|
9/14/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Bio Rad Laboratories (NYSE:BIO.B)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bio Rad Laboratories (NYSE:BIO.B)
Historical Stock Chart
From Sep 2023 to Sep 2024